Small Fiber Neuropathy Clinical Trial
Official title:
Small Peripheral Fibers Assessment Using Cutaneous Silent Period In Normal Individuals In Egypt
Our primary objective in this study is to investigate the cutaneous silent period (CSP) in normal subjects in the Egyptian population, as it was not carried out before in Egypt. The aim was to carry out the test in our unit to study the appropriate method, technique, and parameters of this new test so that we can apply it in future research. In addition, to obtain preliminary normative data of the test; onset latency, end latency, duration, and latency difference (LD) of CSP, as well as assess the effect of age, height, upper limb length, and gender on CSP values.
Nerve conduction studies performed routinely in electromyoneurography laboratories deal mainly with large myelinated fast conducting nerve fibers. A reliable method allowing the study of small peripheral nerve fibers (Aδ & C) would be of interest (Jovita et al., 2006). As they are initially affected and maybe the earliest exhibited sign of neuropathy. In recent years, the cutaneous silent period (CSP) has received increased attention in health and disease. The CSP is an inhibitory spinal reflex that appears following strong electrical stimulation of the cutaneous nerve and causes suppression of voluntary muscular contraction for a certain period of time (Kofler et al., 2019). This action presents a reciprocal action to the nociceptive flexor withdrawal response (FWR) which serves as an 'excitatory reflex' increasing activity in primary flexor muscles. When taken into context, the interplay between the CSP and FWR can clearly be seen. The evaluation of the CSP represents a useful electrophysiological method for investigating the function of small fibers by using standard electromyography equipment (Eckert et al., 2018). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02537951 -
Autofluorescent Flavoprotein Imaging of Intraepidermal Nerve Fibers: a Pilot Study
|
N/A | |
Completed |
NCT01911975 -
Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy
|
Phase 3 | |
Completed |
NCT03304522 -
A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy
|
Phase 2 | |
Recruiting |
NCT04310644 -
Autonomic Small Fiber Neuropathy and Ehlers Danlos Syndromes - Prospective Study and Registry
|
||
Completed |
NCT03912220 -
Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration
|
Phase 2 | |
Completed |
NCT03401073 -
IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3
|
Phase 2 | |
Recruiting |
NCT03889080 -
fMRI-study in Patients With Small Fiber Neuropathy
|
||
Completed |
NCT03447756 -
Titration Study of ABX-1431
|
Phase 1 | |
Recruiting |
NCT04835779 -
Biometric and Biological Data for Diagnosis and Therapy of Pain Patients
|
||
Suspended |
NCT04611048 -
Establishing Normative Values for Thermal Detection and Pain Threshold Established by the Psi Method
|
N/A | |
Not yet recruiting |
NCT04170205 -
Causes Associated With Small Fiber Neuropathy (SFN).
|
||
Recruiting |
NCT05389566 -
Diabetes, Falls, and Fractures
|
||
Terminated |
NCT03339336 -
Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy
|
Phase 2 | |
Recruiting |
NCT05798949 -
Chronic Pain Rehabilitation in Patients With Small Fiber Neuropathy
|
N/A | |
Enrolling by invitation |
NCT05921097 -
Comparison of Histamine and Local Heating for Evoking the Axon-reflex Flare Response in Diabetes
|
||
Completed |
NCT02637700 -
Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy
|
Phase 2 | |
Recruiting |
NCT04759443 -
Detection of Small Fiber Neuropathy Using Skin Properties
|
||
Terminated |
NCT02905396 -
Spinal Cord Stimulation in Small Fibre Neuropathy
|
N/A | |
Completed |
NCT05380804 -
Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
|
||
Recruiting |
NCT03509064 -
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
|